Figure 6.
Combination index and clonogenic survival for Hh/GLI1 inhibition in combination with PARPi. A) Survival graph for various concentration of olaparib treatment in siControl and siGLI1 A2780 cells. B) Survival graph for various GANT61 and olaparib combinations in different ovarian cancer cell lines. C) Combination index for various GANT61 and olaparib combinations as calculated by CalcuSyn software. ** p < 0.01 and *** p < 0.001.